Regulatory T cells (T regs ) are key brakes on the visceral adipose tissue (VAT) inflammation that regulates local and systemic metabolic tenor. Breakdown of this regulation promotes type 2 diabetes. The cytokine IL-33 expands and sustains the unique T reg population residing within VAT. Here, relying on single-cell RNA sequencing, we identified the major IL-33 producers in VAT to be particular mesenchymal stromal cell subtypes, related to but distinct from adipocyte progenitor cells. We explored modulation of the VAT stromal cell landscape with physiologic variables such as age and sex, as well as its remodeling in pathogenic states like obesity. Last, we uncovered a VAT T reg :stromal cell negative regulatory loop that keeps the potent effect of IL-33 under rein.
INTRODUCTION
Innate and adaptive immune system cells exert important positive or negative influences on the sterile inflammation of visceral adipose tissue (VAT) that shapes organismal metabolism (1, 2) . VAT-dwelling anti-inflammatory macrophages (3, 4) , Foxp3 + CD4 + regulatory T cells (T regs ) (5) , and group 2 innate lymphoid cells (ILC2s) (6) are crucial brakes on local inflammation and metabolic dysfunction. In their absence, VAT takes on a pro-inflammatory tenor, and both local and systemic metabolic indices deteriorate, often culminating in type 2 diabetes. Diabetes and its comorbidities are among the 21st century's most important health challenges.
The T reg and ILC2 populations operating within VAT-as well as those functioning in other non-lymphoid tissues-are highly dependent on the cytokine interleukin-33 (IL-33) (6) (7) (8) (9) (10) (11) (12) . It is generally agreed that the major source of IL-33 in murine VAT is non-hematopoietic in nature, but there has been debate over its precise identity, with different investigators invoking endothelial cells (10) or various phenotypes of fibroblast-like stromal cells (8, 13, 14) . As a paradigm of nonhematopoietic cell control of tissular immune/inflammatory responses, we sought to gain a more profound understanding of the VAT IL-33:T reg axis. To that end, we combined multiparameter flow cytometry, confocal microscopy, genetic ablation, and single-cell RNA sequencing (scRNA-seq) to identify and isolate the critical IL-33 + cell types in murine VAT; assessed their modulation with normal physiologic variation and with pathologic perturbation; and elucidated an IL-33-focused VAT T reg :stromal cell regulatory loop.
RESULTS

Identification of IL-33
+ cells in murine VAT To inventorize IL-33-expressing cells in VAT, we prepared a stromal/ vascular cut from the epididymal (e)VAT depot of 8-to 10-week-old male C57BL/6 (B6) mice and distinguished four major cell fractions Confocal microscopy revealed IL-33-expressing cells at diverse sites in the epididymal fat depot. Many of them localized within a ring of connective tissue at the circumference of the depot, presumably the mesothelium (15) (Fig. 1E) . [Note that IL-33 is constitutively expressed in the cell nucleus (16) and so its staining overlaps with that of 4′,6-diamidino-2-phenylindole (DAPI)]. Other IL-33 + cells were located in the interior of the depot-often, but not always, in close association with blood vessels (CD31 staining, Fig. 1F ) and/or neurons (3-tubulin staining, Fig. 1G ).
Because the identity of the critical IL-33 + cells in murine VAT has been somewhat contentious, we used conditional knockout mice to confirm the importance of IL-33 expression by PDGFR + cells, i.e., mSCs in this context. A mouse strain carrying a "floxed" Il33 locus was mated with a strain expressing Cre under the dictates of Pdgfra promoter/enhancer elements. Offspring that were 12 to 16 weeks old were assayed because this is the age when the eVAT T reg population begins to expand, and thus the proliferation-promoting effects of IL-33 (7, 8) are most likely to be evident. As anticipated, ablation of IL-33 expression specifically in PDGFR + eVAT cells had a major impact on whole-tissue Il33 transcript levels ( Fig. 2A) , while total VmSC numbers remained unperturbed ( fig. S3A ). Reflecting the dearth of IL-33, there was a partial diminution of the VAT T reg compartment in eVAT but not iSAT (Fig. 2B) . This reduction was similar to that provoked by whole-body ablation of the IL-33 receptor ST2 encoded by Il1rl1 (Fig. 2C ). In addition, and with both mutations, there were changes in expression of diagnostic eVAT T reg markers: fewer cells expressing ST2, KLRG1, and GATA3, and lower ST2 and KLRG1 mean fluorescence intensities ( fig. S3, B to D) . There was also a trend toward fewer CD25 + T regs in eVAT, but it did not reach statistical significance ( fig. S3E ). Also anticipated was that neither the mSC-preferential loss of IL-33 nor the whole-body ablation of ST2 resulted in a difference in body or VAT weight ( fig. S3F ). Thus, 10-week-old B6 mice using the InDrops protocol (18) . In total, 3720 individual cells were analyzed; on average, 3926 unique mRNA molecules transcribed from 1513 different genes were sequenced per cell. We first displayed the combined data as a t-distributed stochastic neighbor embedding plot, permitting dimensionality reduction. Substantial intra-and inter-tissue heterogeneity was evident: Each tissue hosted five to seven mSC subtypes, which grouped largely according to tissue source (Fig. 3A) . Unsupervised transcript clustering revealed the five VmSC subtypes to have readily distinguishable transcriptomes, with a distinct cluster of overrepresented transcripts for each subtype plus three more complex clusters ( Fig. 3B and table S1 ). Unexpectedly, velocity analysis, which predicts differentiation pathways based on the ratio of spliced to unspliced introns in the totality of mRNAs (19) , failed to reveal clear vectors of differentiation between the various VmSC subtypes (Fig. 3C) , suggesting that they are likely to be independent entities whose transcriptomes have converged to some degree in response to local cues. As anticipated from the sorting strategy, all five VmSC subtypes expressed Pdgfra and Ly6a (encoding Sca-1) transcripts, though at variable frequencies (Fig. 3D, left) . VmSC1 to VmSC3 were the pri- (Fig. 3F  and fig. S4 ). This was an important advance because it allowed validation of the VmSC subtypes defined via scRNA-seq analysis, enabled a deeper phenotypic comparison of these cell populations, and facilitated rapid, cost-effective evaluation of their modulation in diverse physiologic states.
As concerns validation, the relative proportions of the five VmSC subtypes defined according to single-cell transcriptomics and those delineated by cytofluorimetric assessment of marker expression were similar, as were their IL-33 expression levels (as long as mice of the same sex, age, and husbandry were analyzed) (Fig. 3, F and G) . In addition, Spearman correlation analysis of the genes differentially expressed ≥2-fold in the five VmSC scRNA-seq datasets showed a strong correspondence with population-level RNA-seq datasets derived from the analogous cytofluorimetrically sorted VmSC subtypes (Fig. 3H ).
Functional features of the VmSC subtypes
The deeper sequencing coverage afforded by population-level analysis of the individual VmSC subtypes uncovered several additional points of interest. First, all five subtypes expressed high levels of transcripts encoding the pan-fibroblast markers collagen1a2, vimentin, and collagen3a1 (Fig. 4A) . Second, principal component analysis (PCA) showed VmSC2 to be the most divergent of the five populations (Fig. 4B) , consistent with the fact that VmSC2 had more genes ≥2-fold up-or down-regulated vis-à-vis the four other subtypes than did VmSC1 and VmSC3 to VmSC5 (>1100 versus <900). Third, Gene Set Enrichment Analysis (GSEA) revealed an overrepresentation of the "epithelial-mesenchymal transition" pathway, a hallmark of tissue remodeling and fibrosis, in VmSC1 and VmSC2, whereas VmSC4 and VmSC5 showed enrichment for the "adipogenesis" pathway (Fig. 4C and table S2 ). Fourth, analysis of cardinal marker transcripts (20) indicated that VmSC subtype 1 had a clear mesothelial component (Fig. 4D , top, and table S3) and was thus likely to encompass the population of IL-33 + cells at the circumference of the epididymal fat pad (Fig. 1E) . Consistent with the GSEA analysis, VmSC2 was enriched for transcripts encoding markers of proliferation (Fig. 4D, upper middle) , perhaps driving its strong divergence from the other four subtypes. VmSC4 and VmSC5 exhibited the pattern of cardinal transcript overexpression (Pdgfrb, Notch3, and Mcam) and underexpression (Cd34 and Ncam1) expected of pericytes or mural cells (Fig. 4D , lower middle, and table S3) (20) . (Note that subtypes 1 and 3 also showed pericyte signatures, but more weakly, likely corresponding to the vascular IL-33 + cells depicted in Fig 1F. ) VmSC4 and VmSC5 exhibited the strongest expression of diagnostic adipocyte transcripts as well, with VmSC4 seeming to be the more mature of the two cell types (Fig. 4D , bottom, and table S3).
Hence, VmSC subtypes 4 and 5 had phenotypes highly reminiscent of a recently identified mural cell adipocyte precursor residing in murine VAT (21) , concordant with results from a three-dimensional in vitro assay of their adipogenic potential. Sorted VmSC4 and VmSC5 populations, but not the IL-33 + VmSC subtypes, robustly responded to culture in adipogenic medium by enlarging and accumulating neutral lipids in the cytoplasm; actually, these characteristics were already evident, if muted, without adipogenic stimuli (Fig. 4E) fig. S5C and table S4 ) reinforced the notion of VmSC subtype heterogeneity. Note, for example, the particularly low expression of genes encoding extracellular matrix proteins by VmSC2. Thus, the picture that emerged was one of heterogeneous functional potential: an IL-33-producing subtype (VmSC1) that had a mesothelial component, another IL-33-producing subtype (VmSC2) that was proliferating, two Pparg-expressing subtypes (VmSC4 and VmSC5) that could engender adipocytes, and a subtype (VmSC3) that was difficult to pigeonhole.
VmSC subtype evolvement with physiologic variation:
T reg :VmSC1 to VmSC3 correlations Next, we exploited the marker panel to assess modulation of the five VmSC subtypes with normal physiologic variation. Concordant with previous reports (5, 8, 22) , there were significant increases in the fraction and number of eVAT T regs as male B6 mice matured from 6 to 32 weeks of age, particularly for the "true" eVAT-phenotype subpopulation expressing elevated levels of ST2 and GATA3 ( fig.  S6A ) (8) , paralleling rises in body and fat-pad weights ( fig. S6B ). There was also an enrichment in total (Fig. 5A ) and IL-33 + (Fig. 5B ) VmSCs as the mice aged, especially in numbers of VmSC1 to VmSC3 (Fig. 5, C and D) .
Female gonadal (g)VAT, i.e., ovarian (o)VAT, does not show the enrichment in T regs typical of eVAT in males (9) . The root of this divergence remains entirely unknown. Whether mice were 18 to 20 ( fig. S7A ) or 8 to 10 ( fig. S7B ) weeks old, we were able to recapitulate this difference and to add that it applied to true gVAT T regs enriched in cells expressing high levels of ST2 and GATA3. In contrast, there were no significant differences in T reg fractions or numbers in male and female iSAT depots ( fig. S7, A and B S8, A and B) . At both ages, but especially in older individuals, there were more IL-33 + mSCs in the male than in the female gVAT depot (Fig. 6A and fig. S8C ). There was also a very different stromal landscape in the two sexes: more VmSC1, VmSC3, and VmSC4 in males, coupled with fewer VmSC5 (Fig. 6B and fig. S8D ). To determine whether the reduction in gVAT T regs in female mice might reflect limiting IL-33 levels, we injected 8-to 10-week-old females twice with IL-33 and examined T reg levels and phenotype 6 days after the initial injection. There was a strong increase in the fraction and number of T regs in oVAT in response to IL-33 injection ( fig. S8E) , attaining levels at least as high as those observed for eVAT at steady state ( fig. S7A ). The increase was also true of ST2 + , KLRG1 + , and GATA3 + T regs , in particular ( fig. S8F ). Although the dearth of IL-33 + mSCs in female gVAT might explain the defect in local T reg accumulation, we performed headto-head comparative transcriptomics for additional insights. PCA revealed similar intra-sex clustering patterns for the five VmSC subtypes; however, for each subtype, the male and female transcriptomes clustered apart, largely along a single axis, PC2 (Fig. 6C) . Pairwise comparisons highlighted the "fatty acid metabolism" pathway in all cases and early and/or late "estrogen response" pathways in all but the VmSC2 subtype (table S5) . Esr1 transcripts, encoding the estrogen receptor, were much more highly expressed in all female than in male VmSC subtypes (Fig. 6D) . Such a gender difference in Esr1 transcription was not a foregone conclusion-for example, it is not seen with a diversity of immunocyte populations (www.immgen.org). Ar transcripts, encoding the androgen receptor, were also increased in the VmSC1 and VmSC2 populations of females (Fig. 6D) .
Meta-analysis of the aging and gender results, i.e., all of the data from normal physiologic states, revealed highly significant correlations between numbers of ST2 + T regs and VmSC numbers for each of the IL-33-expressing subtypes, above all for VmSC1 (Fig. 6E) . In contrast, there was no correlation with VmSC4 and VmSC5 numbers. This observation reinforces the notion of divergent VmSC subtypes primarily dedicated to promoting immunocytes versus generating adipocytes.
VmSC subtype evolvement with pathogenic perturbation: IL-33-mediated T reg :VmSC cross-talk
To determine whether and how VAT stroma is remodeled under pathogenic conditions, i.e., obesity, we exposed 14-week-old B6 male mice to a high-fat diet (HFD) for 4 (short term) or 16 (long term) weeks. As anticipated (5), the metabolic abnormalities induced by long-term HFD feeding ( fig. S9, A and B) were accompanied by a notable reduction in the VAT T reg compartment, and the few remaining cells had a less VAT-like (i.e., less ST2 + ) phenotype ( fig. S9C ). Total and IL-33-expressing VmSCs were reduced shortly after introduction of the HFD, but by 16 weeks they had bounced back to supraphysiologic levels ( Fig. 7A and fig. S9D ). There was also major remodeling of the VmSC subtype landscape with prolonged HFD feeding, most notably an enrichment in the numbers of all three IL-33 + subtypes ( fig. S9E and Fig. 7B ). Transcriptome analysis indicated that this grouping is probably equivalent to the profibrotic PDGFR + CD9
+ subset of mouse and human VAT stromal cells recently reported to expand with obesity (23) (table S1, cluster g).
Thus, the positive correlation between VAT T reg numbers and IL-33 + VmSC subtype numbers broke down in HFD-induced obesity. An explanation for this observation might be that VAT T regs normally keep IL-33-expressing stromal cells in check, in a negative feedback loop. HFD-induced defects in the size or phenotype of the VAT T reg compartment, as have been documented (5, 7, 22, 24) , might thereby unleash VmSC1 to VmSC3. To test the possibility of IL-33 participation in such a VAT T reg :VmSC regulatory loop, we twice injected this cytokine, 3 days apart, into 10-week-old B6 males, and we analyzed them 6 days after the initial injection. There was no significant increase in the fraction or number of total VmSCs expressing IL-33 in response to this acute treatment (Fig. 7C) , but there was substantial remodeling of the subtype landscape, particularly a large relative decrease in the VmSC1 compartment with a concomitant strong increase in VmSC5 (Fig. 7D) .
Because the mSCs in VAT do not express Il1rl1 transcripts, encoding ST2, at levels significantly above background (≤4), we surmised that the alterations in VmSC subtype distribution were due to indirect effects via another cell type. T regs and ILC2s express the highest levels of ST2 in VAT, and injection of IL-33 expanded both of these lymphocyte subsets in this context (Fig. 8, A and B) . Given the ready availability of more specific reagents, particularly knockout mice, we focused on the contribution of T regs but do not rule out additional participation by ILC2s, the focus of an accompanying paper (25) . Frequent proximity (≤50 m) between T regs and IL-33 + stromal cells was demonstrated by confocal microscopy of eVAT from mice with an enriched VAT T reg compartment (9) for ease of visualization (Fig. 8C) . More importantly, injection of IL-33 into mice lacking ST2 specifically on T regs , in comparison with parallel injections into wild-type littermates, showed muted expansion of the VAT T reg population, particularly the true VAT-phenotype KLRG1 + component (Fig. 8D) (8) ; actually enhanced expansion of the ILC2 compartment (Fig. 8E) ; and allowed a greater increase in total IL-33 + VmSCs (Fig. 8F), especially in subtypes 2 and 3 (fig. S10) . Together, then, the data on obese mice and IL-33-injected wild-type and ST2-deficient mice point to a control loop wherein VAT ST2 + T regs , expanded and sustained by IL-33 in normal physiologic states, negatively regulate IL-33-expressing VmSCs; this loop breaks down in the obese state, with its compromised VAT T reg compartment (Fig. 8G ).
DISCUSSION
Our results highlight mSCs as key orchestrators of metabolic: immunologic cross-talk in adipose tissue. This stromal compartment turns out to be very heterogeneous, both within and between tissues. In healthy individuals, dedicated VAT mSC subtypes coordinately balance immunocyte numbers through secretion of IL-33 (VmSC1 to VmSC3) and adipocyte numbers/activities through regulation of adipocyte precursors (VmSC4 and VmSC5). Remodeling of the VmSC landscape associated with disease states such as obesity [and probably infection (26) ] destroys this harmony, resulting in metabolic and/or immunologic aberrancies. For example, T regs are unable to accumulate in VAT of obese mice (5), likely reflecting modulation of PPAR activity (22, 24) , and thus cannot rein in accumulation of and IL-33 production by VmSC1 to VmSC3 as they do in lean mice. An increase in IL-33 production upon HFD feeding is consistent with the observation that the pro-inflammatory cytokines IL-17 and tumor necrosis factor- synergize to induce IL-33 expression by VAT stromal cells (14) . We have attempted to integrate the VmSC subtypes delineated herein with adipose tissue stromal cell populations recently defined on the basis of other scRNA-seq analyses. Schwalie et al. (27) exclusively studied iSAT rather than the eVAT depots we focused on. The "regulatory" subset they highlighted most closely resembles our VmSC3 subtype on the basis of marker transcript expression [e.g., F3 (CD142) and Abcg1], low transcription of adipogenic genes (e.g., Pparg), and the inability to give rise to adipocytes in culture. However, it is dangerous to extrapolate between depots in this manner, as was also pointed out in the study of Burl et al. (28) . Our total VmSC constellation appears to correspond to what these latter authors termed "adipocyte stem cells," defined by the expression of PDGFR. They also found heterogeneity within this grouping but did not split it into its immunocyte-promoting and adipocyte-generating steadystate components, instead concentrating on adipocyte beiging. Also notable is the identification of mesothelial stromal cells as IL-33 expressers. Mesothelial cells form a cobblestone monolayer surrounding organs in the peritoneal, pleural, and pericardial cavities, constituting a protective layer against physical damage (29) . Hence, these cells would be well placed to exert IL-33's well-established alarmin function (30) . In the VAT context, one can imagine a rheostat role wherein normal expansion of the fat pad (as happens with aging, for example) would induce expression of IL-33, a mechanosensitive cytokine (31), in turn prompting an increase in the VAT T reg and ILC2 populations, and thereby keeping local inflammation in check. SAT is not surrounded by a layer of mesothelium (15) , perhaps explaining the relatively paltry IL-33 and T reg levels in these depots (9) . Whether mesothelium surrounding other organs produces IL-33 to promote adaptive (T regs ) or innate (ILC2s) immune system surveillance of tissue homeostasis remains to be determined, but analogies in lung stromal cell compartments (20) suggest so.
An obvious question is how these observations relate to human adipose tissue. There are Foxp3-expressing cells in human omVAT, fewer in obese than in lean individuals (5) . T regs in human VAT, but not blood, express ST2 (7). Human omVAT has a stromal cell population very similar to the PDGFR + IL-33-producing compartment in mice (13, 23) . Thus, it is likely that our observations will prove true, to at least some degree, in humans as well.
MATERIALS AND METHODS
Study design
The aims of this study were to identify and further characterize the cellular sources of IL-33 within VAT and to determine how these cells correlate with local T regs in diverse physiologic and pathologic states. We performed flow cytometric and confocal imaging experiments to detect IL-33-producing cells, followed by extensive transcriptional profiling at the single-cell population levels, in addition to functional characterization. We studied the abundance and phenotype of IL-33 Egfp lines, and mice lacking IL-33 in mSCs were generated by mating the Il33 flox and Pdgfra-Cre lines. In all cases, mouse lines have been backcrossed to the B6 genetic background for at least eight generations, and experiments were conducted with littermate controls. All animals were housed at the specific pathogenfree facilities at Harvard Medical School (HMS). Experiments were performed under protocols approved by HMS's Institutional Animal Care and Use Committee (protocol #IS00001257). Except where otherwise noted, mice were fed a low-fat diet (no. 5053, Picolab Rodent Diet 20; 13% kcal fat per gram).
Preparation and flow cytometry of adipose tissue samples
Mice were euthanized using CO 2 . eVAT, oVAT, omVAT, iSAT, and BAT were removed, placed into Dulbecco's modified Eagle's medium (DMEM) containing 2% fetal bovine serum (FBS), minced to mechanically disaggregate the tissue, and incubated with collagenase type II (1.5 mg/ml) (Sigma) at 37°C for 20 min with constant shaking in a water bath. Single-cell suspensions were washed with DMEM + 2% FBS, filtered through a 70-m cell strainer, and further washed.
For flow cytometry involving surface staining only, cell preparations were subjected to red blood cell lysis by incubating with 0.5 to 1 ml ammonium-chloride-potassium lysing (ACK) buffer (Lonza) for 1 min on ice, washed, and finally resuspended in DMEM + 2% FBS for surface cytofluorimetric analysis. Staining with Abs recognizing CD45 (103125), CD31 (102406), Sca-1 (108124), PDGFR (135908), and PDPN (127412) (all from BioLegend) was done for ~20 min at 4°C followed by LIVE/ DEAD Fixable Near-Infrared viability dye (Thermo Fisher) incubation for 10 min at room temperature (RT). Following standard surface staining, intracellular IL-33 was detected by fixation and permeabilization using True-Nuclear Transcription Factor Buffer Set (BioLegend) as per the manufacturer's instructions followed by incubation with a goat anti-IL-33 polyclonal primary Ab (#AF326, R&D Systems) and a donkey anti-goat Cy3 secondary Ab (#705-166-147, Jackson Immunoresearch Laboratories). To delineate mSC subsets, we used anti-CD55 (#C62832, LSBio) and anti-Thy1 (#105326, BioLegend) Abs, whereas for T regs and ILC2s, we employed a set of Abs directed against CD45 (#103126, BioLegend), CD4 (#100540, BioLegend), CD8 (#100706, BioLegend), ST2 (#25-9335-82, eBioscience), KRLG1 (#61-5893-82, Invitrogen), and CD25 (#102025, BioLegend), in addition to viability stain with LIVE/DEAD Fixable Yellow dye (Thermo Fisher). For staining of Foxp3, cell suspensions were fixed in eBioscience Fix/Perm buffer for 30 min at RT followed by permeabilization in eBioscience permeabilization buffer and overnight incubation at 4°C with anti-Foxp3 (#17-5773-82, eBioscience) and GATA3 (#12-9966-42, eBioscience). ILC2s were defined as CD45 For 3-tubulin staining, eVAT from B6 retired breeder mice was used. Images were acquired on an Olympus FV1000 confocal microscope and were representative of at least three independent experiments.
PCR quantification
RNA was isolated from a <100-mg fragment of whole eVAT from the distal region using RNeasy Lipid Tissue Mini Kit (Qiagen) and reverse-transcribed using SuperScript Polymerase 2 (Invitrogen) according to the manufacturer's instructions. Real-time quantitative polymerase chain reaction (PCR) was performed using genespecific fluorogenic assays (TaqMan; Applied Biosystems). Total Il33 transcript values were normalized to those from the mouse Hprt gene.
Three-dimensional spheroid in vitro culture of individually isolated VmSC subsets eVAT from at least two mice was pooled, dispersed, and doublesorted using a Moflo Astrios cell sorter based on the VmSC markers mentioned above. Cells (2 × 10 3 to 2.5 × 10 3 ) were collected into a single well from a 384-well ultra-low attachment surface plate (Corning) containing 80 l of DMEM/F12 GlutaMAX (Gibco), 10% FBS, penicillin-streptomycin, and Primocin. Cells were then spun down by centrifugation at 500g for 1 min and incubated in 5% CO 2 at 37°C. After 3 days, culture medium was carefully aspirated, and the cells were exposed to either DMEM/F12 GlutaMAX + 10% FBS and penicillin-streptomycin (maintenance medium) or maintenance medium containing insulin from bovine pancreas (Sigma), 3-isobutyl-1-methylxanthine (Sigma), dexamethasone, and rosiglitazone (Cayman Chemical Company) for an additional 3 days. Cells were washed with PBS, fixed using 4% PFA for 10 min, and stained with HCS LipidTox Green (Thermo Fisher), which has affinity for neutral lipids, for 30 min at RT. Cells were left in Vectashield mounting medium with DAPI at 4°C until acquisition. Spheroids were visualized and imaged using an Olympus FV1000 confocal microscope. Serial pictures covering the spheroids separated by 4 m from one another were taken, which were integrated into a single image using the Z-project function from ImageJ/Fiji software. Spheroid diameter was measured by tracing a line that covered the largest diameter. fl/fl male mice were intraperitoneally injected with either PBS or recombinant mouse IL-33 (BioLegend) at 2 g per dose on days 0 and 3 and were analyzed on day 6. At 14 weeks of age, male B6 mice fed a low-fat diet containing 13% of its calories from fat (no. 5053, Picolab Rodent Diet 20) were either continued on this regimen (LFD group) or fed a HFD providing 60% of its calories from fat (Open Source Diet-D12492, irradiated) (HFD group) for 4 and 16 weeks. These mice underwent metabolic studies beginning at about 8 days before the end of the experiment, when a glucose tolerance test (GTT) was performed. Animals were fasted for an overnight period, weighed, and then evaluated for blood glucose concentrations at 0, 20, 40, 60, 90, and 120 min after intraperitoneal glucose administration (1.0 or 2.0 g/kg for short-or long-term experiments, respectively). The insulin tolerance test (ITT) was performed ~5 days after the GTT-in this case, mice were fasted for 4 hours and injected intraperitoneally with insulin (Humulin R, Lilly; 0.75 or 1.12 U/kg for short-or long-term experiments, respectively). Glucose concentrations were determined at 0, 20, 40, 60, 90, and 120 min afterward. For both GTTs and ITTs, the area under the curve was calculated using GraphPad Prism 7.0.
Mouse manipulations
Quantification of T reg :IL-33
+ cell distances eVAT from 7-or 17-week-old male VAT T reg TCR-transgenic mice expressing the Foxp3-GFP reporter (9) was stained as described above and imaged on an Olympus FV3000 confocal microscope using a 20× objective. Z-stack images of individual 20× fields were stitched together using Fluoview software (Olympus) to generate images of whole eVAT sections and were projected to obtain a twodimensional image for quantification. For determination of the distance between IL-33 + cells and T regs , individual cells were identified using the Analyze Particle function in ImageJ/Fiji and manually verified. The coordinates of IL33 + cells and T regs (anti-GFP Ab staining) were obtained using the measurement function in Fiji, and the distances between these cells were calculated using a Euclidean distance formula. Quantifications were derived from 14 and 7 adipose tissue sections from mice aged 7 to 17 weeks, respectively.
Statistical analyses
Data were routinely shown as mean ± SEM. Unless stated otherwise, statistical significance was determined by the Student's t test or analysis of variance (ANOVA) using GraphPad Prism 7.0. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. A value of more than three SDs from the mean was adopted as criteria to exclude outliers.
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